Nxera Pharma to Host R&D Day 2025

Core Insights - Nxera Pharma Co., Ltd. will hold an R&D Day on 18 November 2025, focusing on its research and development initiatives [1] - The event will be conducted virtually via Zoom, with presentation slides available prior to the meeting [1] Company Overview - Nxera Pharma is a technology-powered biopharmaceutical company dedicated to developing specialty medicines for patients with unmet needs in Japan and globally [2] - The company has established a new-generation commercial business in Japan, focusing on innovative medicines to address a large and growing market in the APAC region [2] Pipeline and Development - Nxera Pharma is advancing a pipeline of over 30 active programs, utilizing its NxWave™ discovery platform, targeting major unmet needs in obesity, metabolic disorders, neurology/neuropsychiatry, and immunology/inflammation [3] - The pipeline includes potentially first- and best-in-class candidates, indicating a strong focus on high-value therapeutic areas [3] Workforce and Locations - Nxera employs approximately 400 people across key locations including Tokyo, Osaka, London, Cambridge, Basel, and Seoul [4] - The company is listed on the Tokyo Stock Exchange under the ticker 4565 [4]